中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction

文献类型：期刊论文

作者Xiong, Jiacheng1,2; Xiang, Yusen3; Huang, Ziming1,2; Liu, Xiaohong1,2,4; Wang, Mengge3; Ge, Guangbo3; Chen, Hongzhuan3; Xu, Jianrong5,6; Zheng, Mingyue1,2; Chen, Lili3
刊名FRONTIERS IN CHEMISTRY
出版日期2021-09-27
卷号9页码:12
关键词SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) spike protein receptor-binding domain (S-RBD) structure-based virtual screening protein-protein interaction (PPI) inhibitors
ISSN号2296-2646
DOI10.3389/fchem.2021.740702
通讯作者Xu, Jianrong(janker.xu@gmail.com) ; Zheng, Mingyue(myzheng@simm.ac.cn) ; Chen, Lili(llchen@shutcm.edu.cn)
英文摘要The emergence and rapid spread of SARS-CoV-2 have caused a worldwide public health crisis. Designing small molecule inhibitors targeting SARS-CoV-2 S-RBD/ACE2 interaction is considered as a potential strategy for the prevention and treatment of SARS-CoV-2. But to date, only a few compounds have been reported as SARS-CoV-2 S-RBD/ACE2 interaction inhibitors. In this study, we described the virtual screening and experimental validation of two novel inhibitors (DC-RA016 and DC-RA052) against SARS-CoV-2 S-RBD/ACE2 interaction. The NanoBiT assays and surface plasmon resonance (SPR) assays demonstrated their capabilities of blocking SARS-CoV-2 S-RBD/ACE2 interaction and directly binding to both S-RBD and ACE2. Moreover, the pseudovirus assay revealed that these two compounds possessed significant antiviral activity (about 50% inhibition rate at maximum non-cytotoxic concentration). These results indicate that the compounds DC-RA016 and DC-RA052 are promising inhibitors against SARS-CoV-2 S-RBD/ACE2 interaction and deserve to be further developed.

WOS关键词RECEPTOR ; BINDING
资助项目Scientific Research Project of Shanghai Municipal Health Commission on Traditional Chinese Medicine for Prevention and Treatment of COVID-19[2020XGKY07] ; Emergency Scientific Research Program of Shanghai University of Traditional Chinese Medicine[2019YJ 06-01] ; National Natural Science Foundation of China[81773634] ; Tencent AI Lab Rhino-Bird Focused Research Program[JR202002] ; Shanghai Science and Technology Innovation Action Plans - Shanghai Science and Technology Committee[20S21901500] ; Shanghai Science and Technology Innovation Action Plans - Shanghai Science and Technology Committee[20S21900900]
WOS研究方向Chemistry
语种英语
WOS记录号WOS:000705528500001
出版者FRONTIERS MEDIA SA
源URL[http://119.78.100.183/handle/2S10ELR8/298451]  
专题新药研究国家重点实验室
通讯作者Xu, Jianrong; Zheng, Mingyue; Chen, Lili
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai, Peoples R China
2.Univ Chinese Acad Sci, Coll Pharm, Beijing, Peoples R China
3.Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China
4.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China
5.Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai, Peoples R China
6.Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China
推荐引用方式
GB/T 7714		 Xiong, Jiacheng,Xiang, Yusen,Huang, Ziming,et al. Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction[J]. FRONTIERS IN CHEMISTRY,2021,9:12.
APA Xiong, Jiacheng.,Xiang, Yusen.,Huang, Ziming.,Liu, Xiaohong.,Wang, Mengge.,...&Chen, Lili.(2021).Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction.FRONTIERS IN CHEMISTRY,9,12.
MLA Xiong, Jiacheng,et al."Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction".FRONTIERS IN CHEMISTRY 9(2021):12.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。